Sipuleucel-T: a therapeutic cancer vaccine for the treatment of castration- or hormone-refractory prostate cancer.

Autor: Bulloch MN; University of Alabama-Tuscaloosa School of Medicine, Department of Internal Medicine, University Medical Center, Box 870326, Tuscaloosa, AL 35487, USA. mjn0004@auburn.edu, Elayan MM, Renfroe HR

Publikováno v: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2011 Nov; Vol. 4 (6), pp. 685-92.

Reflections upon human cancer immune responsiveness to T cell-based therapy.

Autor: Wang, Ena, Tomei, Sara, Marincola, Francesco

Publikováno v: Cancer Immunology, Immunotherapy; Jun2012, Vol. 61 Issue 6, p761-770, 10p